Joseph R. Bertino Memorial Lecture Series
November 4th, 2026
Rutgers Cancer Institute
Auditorium A & B, 4:00 - 5:00 PM
Followed by Reception
This event will celebrate the life of Dr. Joseph R. Bertino, former Interim Director and Chief Scientific Officer of Rutgers Cancer Institute, and examine clinical, laboratory and translational research in the areas of cancer and hematologic disorders. Details and a formal agenda to follow. We hope you will join us.
To support the Joseph R. Bertino Memorial Lecture Series, please visit raise.rutgersfoundation.org/event/bertino.
Speaker: Irene Ghobrial, MD
- Senior Vice President, Experimental Medicine
- Director of the Center for Early Detection and Interception of Blood Cancers
- Co-Leader, Lymphoma/Myeloma Cancer Center Program
- Lavine Family Chair, Preventative Cancer Therapies
- Director, Ghobrial Lab
- Professor of Medicine, Dana-Farber Cancer Institute and
- Harvard Medical School
Previous Years
2025 Program
The 2025 program featured Jonathan Chernoff, MD, PhD, Cancer Center Director, Senior Vice President, and Staney P. Reimann Chair in Oncology Research at Fox Chase Cancer Center. His talk was titled, "Drugging Ras: Up, Down, and Sideways."
2024 Program
View the 2024 program with Yang-Yu Liu, PhD, Associate Professor, Harvard Medical School and Associate Scientist, Brigham and Women’s Hospital.
2023 Program
View the 2023 program with Arnold J. Levine, PhD, Professor Emeritus of Systems Biology, Institute for Advanced Study, who discussed the 'Exploration of the Genetic and Genomic Causes of Cancers of African or European Ancestry.'
2022 Program
View the inaugural 2022 program with speakers:
Frederick W. Alt, PhD ~ 'Anti-Cancer Drug Resistance, Gene Amplification & Beyond'
Charles A. Janeway Professor of Pediatrics Professor of Genetics, Harvard Medical School Investigator, Howard Hughes Medical Institute Director, Program in Cellular & Molecular Medicine, Boston Children’s Hospital
Bruce A. Chabner, MD ~ 'Travels with Joe Along the Folate Highway'
Allen Distinguished Investigator Clinical Director Emeritus, Massachusetts General Hospital
Carl H. June, MD ~ 'Engineered T-Cells as Cancer Therapy'
Director, Center for Cellular Immunotherapies Director, Parker Institute for Cancer Immunotherapy Richard W. Vague Professor in Immunotherapy Professor of Medicine, University of Pennsylvania